IFF Reports First Quarter 2023 Results

Reported net sales for the first quarter were $3.03 billion, flat versus the prior-year period. On a comparable basis2, currency neutral sales increased 1% versus the prior-year period, led by Scent and Pharma Solutions.

→ read the fulll article


Previous post
Eckes-Granini has published its business report 2022 The Eckes-Granini Group concluded the 2022 business year with satisfactory results and is optimistic about the current year 2023.
Next post
Neuro Drinks Founder Diana Jenkins Opens Up About Staying Ahead Of The Curve In Functional Beverages Functional drinks are a multibillion-dollar market globally, and it accelerated further during the pandemic both in terms of consumption volume and the variety of products offering physical and mental benefits.